میترا صوابی

Sexual dysfunction refers to sexual desire disorders and psychosocial changes، which can impact one’s sexual response cycle and cause stress and interpersonal difficulties. Treatment modality is one of the most important predictive factors for sexual dysfunction and varies depending on the type of malignancy. The purpose of this study was to determine the relationship between sexual dysfunctions and treatment modality in gynecologic and breast cancer patients. This correlational study was conducted on 150 women with gynecologic and breast cancers، referring to Seyedoshohada and Milad hospitals in Isfahan، Iran in 2011. The demographic/disease questionnaire، Female Sexual Function Index (FSFI)، and Sexual function-Vaginal changes Questionnaire (SVQ) were completed by the subjects. Student’s t-test and one-way ANOVA were performed، using SPSS version 14. P-value less than 0. 05 was considered statistically significant. As the results indicated، 106 (70. 7%) and 44 (29. 3%) women had breast and gynecologic cancers، respectively. Also، 71 (47. 3%) patients had undergone radiotherapy and chemotherapy. According to ANOVA test results، Sexual dysfunction in patients treated with radiotherapy and chemotherapy was significantly greater than other groups (P=0. 002). Sexual dysfunction in patients with cancers of the breast and genital tract were treated with radiotherapy and chemotherapy was more.

One way to achieve a healthy society is population control and providing effective contraceptive methods. Hormonal contraceptives are the most effective method of birth control. However، their satisfaction rate is affected by many factors. We aimed to study the effective factors on satisfaction from contraceptives including Depot Medroxyprogesterone Acetate (DMPA)، Cyclofem، and low dose (LD) in women who referred to health centers in Isfahan، Iran. This descriptive comparative study was conducted on 150 women who were selected using non-probability sampling during April-October 2010. The subjects were using receive DMPA، Cyclofem، or LD pills for the first time or had used them for less than three months. Data was collected through face to face interviews using a standard questionnaire called ORTHO Birth Control Satisfaction Assessment Tool (BC-SAT) three months after consumption. The data was analyzed using descriptive and inferential statistics. Cyclofem gained the highest mean satisfaction score. There were no significant differences in mean total satisfaction scores assigned by three groups. Although the three groups had significant differences in mean satisfaction scores in ease of use، menstrual impact، and compliance/adherence، no statistically significant differences were observed in lifestyle impact، assurance/confidence، side effects، future fertility concerns، and overall satisfaction. Satisfaction from hormonal contraceptives is influenced by many factors such as knowledge، information، lifestyle، religion، side effects، understanding of individual and others، anxiety، and concerns. On the other hand، satisfaction will in turn influence on the attitudes of individuals.